Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/49709| Title: | Sting-challenge demonstrated tolerance in patients undergoing reduced-dose Jumper ant venom-specific immunotherapy: Validating new center approach in adult and children. | Authors: | Spriggs K.;Leahy E.;Weibel N.;Heke E.;Barnes S. | Institution: | (Spriggs, Leahy, Weibel, Heke, Barnes) Monash Health, Clayton, VIC, Australia (Spriggs) The University of Melbourne, Parkville, VIC, Australia (Barnes) Monash University, Clayton, VIC, Australia |
Issue Date: | 3-May-2023 | Copyright year: | 2023 | Publisher: | American Academy of Allergy, Asthma and Immunology | Place of publication: | United States | Publication information: | Journal of Allergy and Clinical Immunology: In Practice. 11(5) (pp 1570-1571), 2023. Date of Publication: May 2023. | Journal: | Journal of Allergy and Clinical Immunology: In Practice | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.jaip.2023.01.054 | PubMed URL: | 36801490 [https://www.ncbi.nlm.nih.gov/pubmed/?term=36801490] | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/49709 | Type: | Article | Subjects: | headache immunologist immunotherapy insect allergy lip swelling nausea pruritus rash tongue swelling ant venom/ cetirizine fexofenadine immunoglobulin E loratadine tryptase |
Type of Clinical Study or Trial: | Observational study (cohort, case-control, cross sectional, or survey) |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.